11/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
November 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Oct
Dec »
11/2023
Nov 6, 2023, 17:20 |
Blog
Kevin Mahoney: Nursing Recognition Awards
Kevin Mahoney, Chief Executive Officer at the University of Pennsylvania Health System, shared on LinkedIn:…
Nov 6, 2023, 17:14 |
Blog
Bob Li: Cure4Cancer International Movement Global is also local, let's spread the word
Bob Li, Chief Scientific Officer at Memorial Sloan Kettering Cancer Center, shared on LinkedIn: "I…
Nov 6, 2023, 04:03 |
Blog
Paolo Tarantino: Make sure not to miss our presentation of RELIEVE at the San Antonio Breast Cancer Symposium (SABCS23)
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared on X/Twitter: "Trastuzumab Deruxtecan (T-DXd)…
Nov 6, 2023, 03:56 |
Blog
Christine Lovly: Kicking off lung cancer awareness month with a special shout out to the amazing lung community
Christine Lovly shared a post on X/Twitter: "Kicking off lung cancer awareness month with a special…
Nov 6, 2023, 03:51 |
Blog
Liz O'Riordan: I talk about the dangerous cancer diet misinformation that's flooding social media at the moment
Liz O'Riordan shared a post on X/Twitter: "In today's The Lancet David Robert Grimes and…
Nov 6, 2023, 03:46 |
Blog
Eliav Barr: The American Cancer Society published updated lung cancer screening guidelines that expand eligibility
Eliav Barr, Senior Vice President of Global Medical and Scientific Affairs, shared a post on…
Nov 6, 2023, 03:36 |
Drugs
Hagop Kantarjian: Inotuzumab is safe and effective for the eradication of MRD in patients with B-cell ALL, with a MRD negativity rate of 69%
Hagop Kantarjian, Chair of MD Anderson Cancer Center, shared a post on Twitter: Inotuzumab is…
Nov 6, 2023, 03:32 |
Blog
Yuan James Rao: Radiation oncology finances should be taught in US training. Can you answer these?
Yuan James Rao, Director of Brachytherapy at The George Washington University, recently shared on X/Twitter:…
Nov 6, 2023, 03:26 |
Blog
Vivek Subbiah: How to build a successful phase 1 program?
Vivek Subbiah posted the following on X/Twitter: "How to build a successful phase 1 program? -…
Nov 6, 2023, 03:22 |
Blog
C. Ola Landgren: The launching of a new computational oncology fellowship/post-doc opportunity
Quoting C. Ola Landgren, Leader of Experimental Therapeutics at Sylvester Comprehensive Cancer Center, on LinkedIn:…
56
57
58
59
60
All:
709
Posts:
571 - 580
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube